# Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation

> **NCT00948727** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 39 (actual)

## Conditions studied

- Hematopoietic Stem Cell Transplantation
- Graft Versus Host Disease

## Interventions

- **BEHAVIORAL:** Dose adaptation according to CN activity monitoring
- **DRUG:** Cyclosporine (CsA)

## Key facts

- **NCT ID:** NCT00948727
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2006-09
- **Final completion:** 2008-06
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2009-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00948727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00948727, "Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00948727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*